OAR 855-041-6270
Labeling
(1)
Each pharmacy record keeping system must identify and document the pharmacist who verifies the drug.(2)
Each pre-packed drug, including a unit-dosed drug, prepared by the pharmacy and intended for use within the facility shall be in an appropriate container with a label that contains:(a)
The brand or generic name and expiration date;(b)
The manufacturer and lot number, or an internal pharmacy code that references manufacturer and lot number;(c)
The strength of the drug.(3)
In-patient: Each drug dispensed to an in-patient other than in a unit-dose or manufacturer’s unit-of-use packaging must be labeled with the following information:(a)
Name and location of patient;(b)
Name and strength of drug;(c)
Route of administration, when necessary for clarification;(d)
Manufacturer and lot number, or internal pharmacy code;(e)
Auxiliary labels as needed, and(f)
Expiration date.(4)
A drug that is to be sent with the patient upon discharge must be labeled in accordance with ORS 689.505 (Labeling requirements)(5) and other rules in this Division. Drug counseling information must be provided to the patient or patient’s agent.(5)
A label for an outpatient prescription must comply with ORS 689.505 (Labeling requirements)(5) and other rules in this Division.(6)
New bar coding or electronic label: When a new barcode or electronic label is used to identify a drug the pharmacist must verify and document the accuracy of the identification with all electronic verification systems prior to distribution.(7)
Whenever a drug is added to a parenteral solution under the direct supervision of a pharmacist, the admixture must be labeled with a distinctive supplementary label that contains(a)
The name, quantity and concentration of the drug added and the primary solution;(b)
The date and time of addition;(c)
The expiration date;(d)
The scheduled time for administration;(e)
The infusion rate, when applicable;(f)
The name or initials of person performing admixture;(g)
The identification of the pharmacy where the admixture was performed; and(h)
The name or initials of the verifying pharmacist.(8)
The label applied at a secondary storage or remote storage area by a nurse or physician must include: the patient name or patient identifier, quantity and concentration of the drug added and the primary IV solution; the date and time of addition and the initials of the nurse or physician adding the drug.
Source:
Rule 855-041-6270 — Labeling, https://secure.sos.state.or.us/oard/view.action?ruleNumber=855-041-6270.